After Covishield maker AstraZeneca initiated the worldwide withdrawal of its COVID-19 vaccine, manufacturer Serum Institute of India said, "From the outset, we've disclosed all rare...side-effects, including Thrombosis with Thrombocytopenia Syndrome, in the packaging insert in 2021." "We fully understand the ongoing concerns and it's crucial to emphasise our commitment to transparency," it added.
short by
Arshiya Chopra /
09:12 pm on
08 May